From: BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis
Search engine | Search strategy | Additional filter | Result |
---|---|---|---|
PubMed/Medline | ((“Uterine Neoplasms“[Mesh]) OR (“Endometrial Neoplasms“[Mesh]) OR (“Genital Neoplasms, Female“[Mesh]) OR (“Uterine Cervical Neoplasms“[Mesh]) OR (“Carcinoma, Endometrioid“[Mesh]) OR (“Atypical Squamous Cells of the Cervix“[Mesh]) OR (“Sarcoma, Endometrial Stromal“[Mesh]) OR (“Endometrial Stromal Tumors“[Mesh])) AND ((“BRCA2 Protein“[Mesh]) OR (“BRCA1 Protein“[Mesh]) OR (“BRCA1 Protein / genetics”) OR (“BRCA2 Protein / genetics”)) | English, 2020 | 668 |
Scopus | ((TITLE-ABS-KEY (uterine AND neoplasms) OR TITLE-ABS-KEY (endometrial AND neoplasms) OR TITLE-ABS-KEY (uterine AND cervical AND neoplasms) OR TITLE-ABS-KEY (endometrial AND stromal AND tumors) OR TITLE-ABS-KEY (endometrial AND carcinoma)) AND PUBYEAR > 2013 AND PUBYEAR < 2024) AND ((TITLE-ABS-KEY (brca2 AND protein) OR TITLE-ABS-KEY (brca1 AND protein)) AND PUBYEAR > 2013 AND PUBYEAR < 2024) | English, 2014 | 598 |
Google scholar | All intitle: BRCA Uterine All intitle: BRCA Endometrial Also, we checked the recent Systematic reviews references manually. | English | 105 |